a year ago

Bicycle Therapeutics Secures $555M for Cancer Treatment Innovation

  • Bicycle Therapeutics, a Cambridge-based medtech company, has raised $555 million in equity financing via a private placement

  • The company is focused on using 'bicycle' molecules to treat cancer by penetrating solid tumours

  • The financing was led by a US-based healthcare-focused investor with participation from Deep Track Capital, EcoR1 Capital, Fairmount, Forbion, Perceptive Advisors and RA Capital Management.

      • ProblemHealthcare

      "Current cancer treatments are often ineffective and have severe side effects. Patients need more effective and targeted treatments with fewer side effects."

      Solution

      "Bicycle Therapeutics develops 'bicycle' molecules, which are small, synthetic peptides that can penetrate solid tumors and target cancer cells. These molecules are designed to be more effective and have fewer side effects than traditional treatments."

      Covered on